GLP-1 & Metabolic Research Emerging

5-Amino-1MQ

Small molecule NNMT inhibitor studied for its potential in obesity and metabolic disease research contexts.

nnmtmetabolicadiposeobesityenergy

Ask AI About This Compare Compounds

Half-life

Estimated 2–4 hours based on preclinical data

SKUs

Evidence

Emerging

📖 What Is This?

5-Amino-1MQ is a small molecule compound that researchers have been studying as a potential tool in metabolic health research. It works by blocking a specific enzyme called NNMT, which plays a role in how the body stores and burns fat. Most of the research so far is in animal models, and the compound has not yet been tested in large human clinical trials.

🔬 What Are Researchers Studying It For?

Metabolic Research

Preclinical studies in mice have examined whether NNMT inhibition can improve metabolic markers including body fat, blood sugar regulation, and energy expenditure. Early results in rodent models showed reductions in fat mass without significant changes in lean mass.

Adipose Tissue Biology

NNMT is particularly active in fat tissue, and researchers have studied whether blocking it changes how fat cells store and release energy. Animal studies suggest it may shift fat cells toward a more metabolically active state.

Obesity Research

Some preclinical work has positioned 5-Amino-1MQ as a candidate for obesity research given its proposed mechanism of increasing energy expenditure through changes in fat tissue metabolism. Human translation has not been established.

📊 What Does The Research Suggest?

Reduced fat mass in rodent models of obesity without significant effects on lean tissue.
Changes in fat cell gene expression consistent with increased metabolic activity in animal studies.
No large-scale human clinical trial data published to date.
Mechanism of action (NNMT inhibition) is supported by biochemical research but human effects are unconfirmed.

⚠️ What Should You Know Before Going Deeper?

Research on 5-Amino-1MQ is at an early stage. The published studies are primarily in mice, and the human pharmacokinetics, effective dose range, and safety profile have not been established in clinical trials. Results from rodent metabolic studies often do not translate directly to humans. This compound is not approved for any use and should be considered investigational.

⚙️ How It Works In The Body

Your body has an enzyme called NNMT — nicotinamide N-methyltransferase — that regulates a process related to how fat cells manage energy. When NNMT is very active, it tends to be associated with a slower metabolic state in fat tissue. 5-Amino-1MQ is designed to block this enzyme. In theory, turning down NNMT activity could shift fat cells toward burning more energy and storing less. Researchers are studying whether this translates into meaningful changes in body composition or metabolic health, but that question has not been answered in humans yet.

🛡️ Research Safety Observations

The safety profile of 5-Amino-1MQ in humans has not been established through clinical trials. Animal studies did not report concerning toxicity at tested doses, but this cannot be used to infer human safety. It is not FDA-approved for any purpose. Human dosing guidance does not exist in the published literature.

📋 Research Snapshot

Emerging

This compound is in early-stage research. Evidence is limited to small studies or in vitro data.

Published Research Ranges

Primarily preclinical; human dosing ranges not established in published literature

Research Context Only: These are ranges reported in published scientific studies for educational reference. They are not dosing recommendations. This is not medical advice. Always consult a qualified healthcare professional.

📄 Research Sources

Sources listed here are from the platform research library. All links open the original publication. No citations are generated by AI.

NNMT Inhibition with 5-Amino-1MQ Prevents Diet-Induced Obesity in Mice

Cell Chemical Biology • 2021 • DOI: 10.1016/j.chembiol.2021.02.012

5-Amino-1MQ

Want More Detailed Research?